Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;101(2):108-113.
doi: 10.1111/cen.15080. Epub 2024 May 26.

Severe adrenal insufficiency in six neonates with normal newborn screening for CAH

Ilknur Kurt  1 , Metin Eser  2 , Ahmet Kahveci  1 , Ahmet Ucar  3 , Derya Bulus  4 , Bahar Ozcabi  5 , Omer Guran  6 , Selen Karagozlu  7 , Aysenur Ersoy  8 , Senol Demir  8 , Bilge Geckinli  8 , Tulay Guran  1
Affiliations

Severe adrenal insufficiency in six neonates with normal newborn screening for CAH

Ilknur Kurt et al. Clin Endocrinol (Oxf). 2024 Aug.

Abstract

Background: Newborn screening (NBS) reduces the risk of mortality in congenital adrenal hyperplasia (CAH), mainly due to the salt-wasting form of 21-hydroxylase deficiency. There is limited knowledge regarding the results of NBS in non-CAH primary adrenal insufficiency (non-CAH PAI).

Patients and methods: Clinical and NBS for CAH data of neonates who were diagnosed with non-CAH PAI between January and December 2022 were examined.

Results: Patients (n = 6, 4 females) were presented with severe hyperpigmentation (n = 6), hypoglycemia (n = 4), hyponatremia (n = 3), hyperkalemia (n = 1), respiratory distress syndrome (n = 1) between 3rd hour to 2 months of life. All had normal NBS results. The median first-tier 17-hydroxyprogesterone (17OHP) concentration in NBS for CAH was 0.14 ng/mL (range; 0.05-0.85). Molecular studies revealed biallelic mutations in the MC2R (n = 4; 3 homozygous, 1 compound heterozygous), MRAP (n = 1) and STAR (n = 1) genes. Glucocorticoid with or without mineralocorticoid replacement was initiated once the diagnosis of non-CAH PAI was established.

Conclusion: Neonates with non-CAH PAI have always normal NBS due to persistently low 17OHP, even when these newborn infants are severely symptomatic for adrenal insufficiency. Clinicians should be alert for signs of adrenal insufficiency in neonates, even if the patient has a 'normal' screening for CAH, so as not to delay diagnosis and treatment. This fact should be kept in mind particularly in countries where these conditions are more common than elsewhere.

Keywords: MC2R; MRAP; STAR; newborn screening for CAH; non‐CAH primary adrenal insufficiency.

PubMed Disclaimer

References

REFERENCES

    1. Claahsen‐van der Grinten HL, Speiser PW, Ahmed SF, et al. Congenital adrenal hyperplasia‐current insights in pathophysiology, diagnostics, and management. Endocr Rev. 2022;43(1):91‐159. doi:10.1210/endrev/bnab016
    1. Speiser PW, Arlt W, Auchus RJ, et al. Congenital adrenal hyperplasia due to steroid 21‐Hydroxylase deficiency: an endocrine society clinical practice guideline. J ClinJl Endocrinol Metabol. 2018;103(11):4043‐4088. doi:10.1210/jc.2018-01865
    1. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32(1):81‐151. doi:10.1210/er.2010-0013
    1. Amano N, Narumi S, Hayashi M, et al. Genetic defects in pediatric‐onset adrenal insufficiency in Japan. Eur J Endocrinol. 2017;177(2):187‐194. doi:10.1530/eje-17-0027
    1. Buonocore F, Maharaj A, Qamar Y, et al. Genetic analysis of pediatric primary adrenal insufficiency of unknown etiology: 25 years' experience in the UK. J Endocr Soc. 2021;5(8):bvab086. doi:10.1210/jendso/bvab086

Substances